tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Revenue

Compare
358 Followers

Keros Therapeutics Revenue

Keros Therapeutics had a revenue of 14.26M in the quarter ending Sep 30, 2025, with -21.50%. This bring the company's revenue in the last twelve months to 246.72M, Decreased 5.96%. In the fiscal year ending Dec 31, 2024, Keros Therapeutics had annual revenue of 3.55M with 2250.99% growth.
Revenue (ttm)
246.72M
Revenue Growth
37798.31%
P/S Ratio
184.60
Revenue/Employee
$21,779
Employees
163
Market Cap
$655.33M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
3.55M3.40M+2,351.01%
Dec 31, 2023
151.00K-15,100,000.00%
Dec 31, 2022
-20.10M
Dec 31, 2021
20.10M-2,010,000,000.00%
Dec 31, 2020
-10.00M
Dec 31, 2019
10.00M0.00+100.00%
Dec 31, 2018
10.00M